JScreen is a national community-based public health initiative dedicated to preventing Jewish and other genetic diseases. Headquartered in Emory University School of Medicine’s Department of Human Genetics, JScreen provide a ready access point to cutting-edge genetic testing technology, patient education and genetic counseling services.
In addition to providing onsite screening at events across the U.S., the program brings screening to people in the comfort of their homes. Through JScreen, people can register online 24/7, receive a saliva collection kit in the mail, send in a sample, and receive results by phone or secure videoconference with JScreen genetic counselors. JScreen’s carrier screening panel tests for more than 200 diseases, many of which are common in Ashkenazi, Sephardi and Mizrahi communities, and others that are common in the non-Jewish population, addressing the needs of all Jewish groups, interfaith couples and other populations. JScreen’s comprehensive carrier screening helps couples plan ahead for the health of their future families.
For information about the JScreen program, go to https://jscreen.org/
Ashkenazi Jews are at 10 times greater risk for mutations in the BRCA genes that increase their risk for breast, ovarian, prostate and pancreatic cancers, even without personal or family histories of these cancers. If a person knows they have a mutation, they can take action to help prevent cancer. Emory’s JScreen program recently launched the PEACH BRCA Study that offers FREE at-home education, testing and genetic counseling services for Atlanta men and women with Ashkenazi background who do not have personal or family histories of these cancers.
For information about the study, go to https://jscreen.org/brca/. For questions, email firstname.lastname@example.org or call 404-778-8640.